Dr Elena Zamagni is Assistant Professor of Hematology at the University of Bologna, Italy. Her research interests include areas related to multiple myeloma, in particular on the role of high dose therapy with stem cell support, of prognostic factors and of imaging techniques.
She has published over 90 papers in peer-reviewed journals, mainly in the field of plasma cell dyscrasia. She is an active member of the Italian GIMEMA myeloma working party. She is a member of the Italian Society of Haematology and of the International Myeloma Working Group and served on the EHA’s Scientific Program Committee since 2017.